Premium
Successful use of baricitinib in the treatment of refractory rheumatoid arthritis‐associated Sweet syndrome
Author(s) -
Nousari Y.,
Wu B. C.,
Valenzuela G.
Publication year - 2021
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.14712
Subject(s) - medicine , leflunomide , hydroxychloroquine , rheumatoid arthritis , rheumatoid factor , dermatology , infliximab , prednisone , arthritis , etanercept , rituximab , gastroenterology , surgery , lymphoma , disease , covid-19 , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom